Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000023

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 25, 2018
Accepted (ET)
May 2, 2018 · 1:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockApr 25, 2018P1,000$0.0351A24,975,789D
Common StockApr 25, 2018P1,000$0.0366A24,976,789D
Common StockApr 26, 2018P1,000$0.036A24,977,789D
Common StockApr 26, 2018P1,000$0.036A24,978,789D
Common StockApr 26, 2018P1,000$0.034A24,979,789D
Common StockApr 26, 2018P1,000$0.034A24,980,789D
Common StockApr 26, 2018P1,000$0.034A24,981,789D
Common StockApr 26, 2018P2,000$0.034A24,983,789D
Common StockApr 27, 2018P1,000$0.034A24,984,789D
Common StockApr 27, 2018P1,000$0.0337A24,985,789D
Common StockApr 27, 2018P1,000$0.0335A24,986,789D
Common StockApr 27, 2018P1,000$0.0335A24,987,789D
Common StockApr 27, 2018P2,000$0.0333A24,989,789D
Common StockApr 27, 2018P1,000$0.0323A24,990,789D
Common StockApr 27, 2018P1,000$0.034A24,991,789D
Common StockApr 27, 2018P1,000$0.031A24,992,789D
Common StockApr 27, 2018P100$0.0339A24,992,889D
Common StockApr 30, 2018P1,000$0.03A24,993,889D
Common StockApr 30, 2018P1,000$0.032A24,994,889D
Common StockApr 30, 2018P1,000$0.032A24,995,889D
Common StockApr 30, 2018P1,000$0.032A24,996,889D
Common StockApr 30, 2018P100$0.0327A24,996,989D

Table II — derivative securities

No Table II lines on this filing.